EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Routine HbA1c monitoring and cardiovascular outcomes in diabetes: Evidence from a large Spanish cohort

Domingo Orozco-Beltran, Samuel Seidu, Jose Antonio Quesada

Primary Care Diabetes · 2026

DOI: 10.1016/j.pcd.2025.11.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Primary Care Diabetes, 2026. Verfasst von Domingo Orozco-Beltran und 2 weiteren Autor:innen. Beteiligte Einrichtung: Primary Care Research Center CIAP, Department of Clinical Medicine, University of Miguel Hernández Elche, Comunidad Valenciana, Spain. Hauptthemen laut MEDLINE: Glycated Hemoglobin, Cardiovascular Diseases, Diabetes Mellitus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, National Institute for Health and Care Research, NIHR Leicester Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM Glycated hemoglobin (HbA 1c ) is a key indicator of diabetes control. However, the risk of missing HbA 1c values in clinical records is unknown. We aimed to analyze the relationship between missing HbA 1c values and the occurrence of major cardiovascular events or death from all causes.

Methods

Retrospective cohort study based on a national database of primary care electronic medical records in Spain (BIFAP). We included people aged 30 years and older with an incident diagnosis of diabetes mellitus. Follow-up started on the date of diabetes diagnosis between 2005 and 2019, and ended on occurrence of composite endpoint (major cardiovascular events and/or death from all causes), or December 31st , 2019. The baseline exposure variable was HbA 1c ( 8 %, missing). Cox models were fitted.

Results

Our analysis included 303,199 people with diabetes, with an average age of 62.2 years and 44.7 % were women. The mean follow-up was 5.7 years, and 10.2 % of patients had missing HbA 1c values. The cardiovascular risk was 1.18 (95 %CI: 1.14–1.22) in the HbA 1c 7 %-8 % group, 1.41 (95 %CI: 1.36–1.46) in HbA 1c > 8 %, and 2.95 (95 %CI: 2.89–3.05) in HbA 1c missing, compared with HbA 1c < 7 %.

Conclusions

In this large cohort of people with newly diagnosed diabetes, missing HbA1c values was associated with a significantly higher risk of major cardiovascular events or death, more than double the risk observed in people with the worst glycemic control. These findings underscore the clinical importance of routinely recording and monitoring HbA1c at diagnosis, not only as a marker of metabolic control but also as a potential prognostic indicator. The lack of HbA1c may act as an indicator of suboptimal clinical follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycated HemoglobinCardiovascular DiseasesDiabetes MellitusHumansFemaleSpainMaleMiddle AgedRetrospective StudiesAgedBiomarkersRisk AssessmentPredictive Value of TestsTime FactorsBlood GlucoseAdultElectronic Health RecordsDatabases, FactualPrognosisRisk FactorsPrimary Health CareHeart Disease Risk Factors

Stichwörter der Autor:innen

Cardiovascular disease riskElectronic patient recordsGlycosylated hemoglobinSpainUncontrolled diabetes

Substanzen

Glycated Hemoglobinhemoglobin A1c protein, humanBiomarkersBlood Glucose

Autor:innen und Institutionen

  • Primary Care Research Center CIAP, Department of Clinical Medicine, University of Miguel Hernández Elche, Comunidad Valenciana, Spain.
  • Diabetes Research Centre, College of Medicine, Biological Sciences and Psychology, University of Leicester, Leicester LE5 4PW, UK; NIHR Applied Research Collaboration, Leicester, East Midlands LE5 4PW, UK. Electronic ad…
  • Primary Care Research Center CIAP, Department of Clinical Medicine, University of Miguel Hernández Elche, Comunidad Valenciana, Spain; GRINCAVA Cardiovascular Research Group, Department of Clinical Medicine, University…

Förderung

  • British Heart Foundation
  • National Institute for Health and Care Research
  • NIHR Leicester Biomedical Research Centre
  • NIHR Imperial Biomedical Research Centre

Zitieren

APA

Orozco-Beltran, D., Seidu, S., & Quesada, J. A. (2026). Routine HbA1c monitoring and cardiovascular outcomes in diabetes: Evidence from a large Spanish cohort. Primary Care Diabetes. https://doi.org/10.1016/j.pcd.2025.11.012

Vancouver

Orozco-Beltran D, Seidu S, Quesada JA. Routine HbA1c monitoring and cardiovascular outcomes in diabetes: Evidence from a large Spanish cohort. Primary Care Diabetes. 2026. doi:10.1016/j.pcd.2025.11.012

BibTeX
@article{OrozcoBeltran2026,
  author = {Orozco-Beltran, Domingo and Seidu, Samuel and Quesada, Jose Antonio},
  title = {Routine HbA1c monitoring and cardiovascular outcomes in diabetes: Evidence from a large Spanish cohort},
  journal = {Primary Care Diabetes},
  year = {2026},
  doi = {10.1016/j.pcd.2025.11.012}
}
Kostenlos starten →